biospecimen__admin__batch_number	405.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	CCA087AC-D830-48B2-954D-D992DD11F411
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-3K-AAZ8-01A-12R
biospecimen__bio__bcr_portion_barcode	TCGA-3K-AAZ8-01A-12
biospecimen__bio__bcr_sample_barcode	TCGA-3K-AAZ8-01A
biospecimen__bio__biospecimen_barcode_bottom	0167787936
biospecimen__bio__day_of_creation	25
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-3K-AAZ8.61B69388-FA7E-4AE5-A3F5-104BCE12284F.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A39D
biospecimen__bio__plate_row	H
biospecimen__bio__quantity	2.08
biospecimen__bio__subportion_sequence	2
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-3K-AAZ8
biospecimen__shared__patient_id	AAZ8
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	FCED3272-24D0-44A3-AB5F-0857DEE833E1
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__fibrosis_ishak_score	5 - Nodular Formation and Incomplete Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis C
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__clin_shared__age_at_initial_pathologic_diagnosis	65
clinical__clin_shared__bcr_followup_barcode	TCGA-3K-AAZ8-F69330
clinical__clin_shared__bcr_followup_uuid	00DE20A5-53ED-419B-945A-1460F560942C
clinical__clin_shared__day_of_form_completion	25
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	8
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	RX
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	151
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Locoregional Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-3K-AAZ8-D64051
clinical__rx__bcr_drug_uuid	53F09997-1A79-41DE-A307-66747EA290B2
clinical__rx__days_to_drug_therapy_start	304
clinical__rx__drug_name	Regorafenib
clinical__rx__therapy_ongoing	NO
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G1
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T3b
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	ab14829c-defd-41b9-b35d-2876049cb46b
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-3K-AAZ8-01A-12R-A39D-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	ca9feaae-c00a-443d-a053-7e17e7c70937,ee5307d3-921e-469c-bff1-bde97b68955e,9d5dc4f1-3b26-4314-9f9d-395da1d3566f
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - FPKM,HTSeq - Counts,HTSeq - FPKM-UQ
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.9
gdc__analytes__analyte_id	eb2794ad-535a-4588-b06e-847eafb135d0
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	94e387ae-b641-4e9f-bb53-22c7b2a9cccb
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-29T10:54:13.708546-05:00,2016-05-29T10:54:13.357877-05:00,2016-05-29T10:54:13.523608-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	5f3e7317-49fd-5c72-9772-97078861672e
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	black or african american
gdc__demographic__year_of_birth	1948
gdc__diagnoses__age_at_diagnosis	24046
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24046.0
gdc__diagnoses__days_to_last_follow_up	396.0
gdc__diagnoses__diagnosis_id	cf7bc27c-a62b-5b3b-a9ed-312f1801e81b
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiib
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	28.393726338561383
gdc__exposures__exposure_id	1cdc47fb-5f3b-567e-b320-cce8c4c9052f
gdc__exposures__height	172.0
gdc__exposures__weight	84.0
gdc__file_id	3759d7a8-b89f-41cd-beb3-8da0a8a18924,f09f1f87-7318-40b9-ad59-a9c70a036b9a,56cb811c-b6da-45dc-ae1c-015298e1fd93
gdc__file_name	0069f64b-8d8f-4426-968d-23483929ee58.FPKM.txt.gz,0069f64b-8d8f-4426-968d-23483929ee58.htseq.counts.gz,0069f64b-8d8f-4426-968d-23483929ee58.FPKM-UQ.txt.gz
gdc__file_size	480507,244983,481875
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	92fa6a00ec5f4577d55ecdf6aa63ad63,67478087aa8375bc942268da94a085ab,16ff938f633d17638d9ff165f738ae3b
gdc__portions__is_ffpe	false
gdc__portions__portion_id	d7e852ac-3979-4943-ab2d-d6d2b5a3b688
gdc__portions__portion_number	12
gdc__portions__weight	20.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	65
gdc__samples__initial_weight	230.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	61B69388-FA7E-4AE5-A3F5-104BCE12284F
gdc__samples__sample_id	bb485b2f-3a35-41e1-81b8-d6b0ba4f8a64
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	4.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	1.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	3.0
gdc__slides__percent_tumor_cells	96.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	2fe2a5d5-4e48-4128-bfea-5fdf64ad9765
gdc__submitter_id	0069f64b-8d8f-4426-968d-23483929ee58_fpkm,0069f64b-8d8f-4426-968d-23483929ee58_count,0069f64b-8d8f-4426-968d-23483929ee58_uqfpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	3K
gdc__tissue_source_site__name	Boston Medical Center
gdc__tissue_source_site__tissue_source_site_id	b7e5500b-b955-5cde-a867-d96d6a24bac9
gdc__treatments__treatment_id	f1a89da8-55ec-5c61-bc52-3aa77be5e07d
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:09:43.196+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/ab14829c-defd-41b9-b35d-2876049cb46b-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/ab14829c-defd-41b9-b35d-2876049cb46b-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5020638
manually_curated__local_md5	4b7fc5c3fe6405ea01e7c2aa6d959ef2
manually_curated__opengdc_download_date	2018-10-15T16:30:01.000706+02:00
manually_curated__opengdc_file_md5	849edf7dfc32856fccc16bd8ecb2db92
manually_curated__opengdc_file_size	1632773
manually_curated__opengdc_id	ab14829c-defd-41b9-b35d-2876049cb46b-geq
manually_curated__origin_file_size	5020638
manually_curated__origin_last_modified_date	Mon Oct 15 16:41:00 CEST 2018
manually_curated__origin_md5	4b7fc5c3fe6405ea01e7c2aa6d959ef2
manually_curated__tissue_status	tumoral
num	60483
